Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to manufacture and sell its proprietary ...

NaaS Technology Inc. ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that management will participate in the following upcoming investor ...